Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.00 (0.00%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £18.01m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

5 Dec 2023 07:00

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, December 05

5 December 2023

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2023 (the “Period”).

Chairman’s Statement

Following the announcement with Marechale’s full year results released in August 2023, the market continues to remain challenging, particularly in the hospitality sector. However, the Board remains positive about the outlook for its investments.

Marechale Capital continues to see interesting corporate finance and advisory projects where it can take founders shares and warrants as part of its advisory fees. On a positive note, Marechale has completed transactions during the period for the European telecommunications technology company, Fast2fibre, Chestnut Group, the leading East Anglian Inn Group, and for Brewhouse & Kitchen, the expanding gastro pub business. However, the market remains a difficult environment in which to raise capital. This has resulted in some advisory projects that launched in the summer not being completed by the end of the Period. Marechale continues to look for new funding partners alongside its traditional investor relationships.

During the six months ended 31 October 2023, the Company generated gross profits of £93,813 (2022: £72,020) and delivered an operating loss of £155,421 (2022: loss of £178,995), resulting in an overall loss before tax of £155,803 (2022: loss of £179,502).

The Company’s balance sheet shows a net asset value of £3,340,486 (2022: £3,456,430), representing 3.15p (2022: 3.62p) of value per share in issue. The Company remains positive about the investments that it holds in its client companies. As at 31 October 2023 the Company had £400,000 of cash reserves.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with Chris Kenning, following his strategic investment of 9.9% of the Company announced in June 2023. The plan is to digitise Marechale’s activities and continue to develop strategic partnerships with the objective of enhancing shareholder value.

Marechale also uses its balance sheet to co-invest in its client companies, along with warrants and founder equity. Furthermore, the Board is hopeful to be able to announce realisations on some of the Company’s investments in the next six months

Whist the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

For further information please contact:

Marechale CapitalMark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLPJo Turner / Sandy Jamieson Tel: +44 (0)20 7213 0880
Income Statement (unaudited)
6 months ended 31 October20232022
£
Revenue320,603168,001
Cost of sales(226,790)(95,981)
Gross profit 93,81372,020
Administrative expenses(249,235)(251,015)
Operating loss(155,421)(178,995)
Interest paid(382)(507)
(Loss/profit before tax(155,803)(179,502)
Taxation--
(Loss)/profit after tax(155,803)(179,502)
(Loss)/profit per share
(Pence)(Pence)
- Basic(0.15)(0.19)
- Diluted(0.14)(0.19)
Balance Sheet (unaudited)
As at31 October31 October
20232022
Current assets
Available for sale investments2,863,2273,116,441
Trading investments130,076146,589
Trade and other receivables37,21954,356
Cash and cash equivalents398,229246,808
3,428,7513,564,194
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(51,278)

(9,487)

(10,000)

(59,627)

(10,638)

(10,000)

Total current liabilities(70,765)(80,265)
Net current assets3,357,9863,483,929
Bounce-back Loan – long-term(17,500)(27,500)
Net assets3,340,4863,456,429
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

847,530

481,290

763,023

328,413

Reserve for own shares(50,254)(50,254)
Retained profits/ (losses)1,944,8422,346,660
Reserve for share based payments117,07868,587
3,340,4863,456,429
Cash Flow Statement (unaudited)
6 months ended31 October31 October
20232022
££
Net cash from operating activities
Loss after tax (155,803)(179,502)

Provision for share based payments

Reverse interest paid

33,091

381

6,275

507

Operating cash flows before movements in working capital(122,331)(172,720)
Movement in working capital
Decrease/ (increase) in receivables38,714(10,580)
(Decrease)/ Increase in payables(30,795)12,895
Net movement in working capital7,9192,315
Operating cash out-flow(114,412)(170,405)
Investment activities
Expenditure on available for sale investments(572)-
Proceeds from sale of investments-8,750
Cash flow from investing activities(572)8,750

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

235,800

(5,000)

(381)

230,419

-

(5,000)

(507)

(5,507)

Net increase/ (decrease) in cash and cash equivalents115,435(167,162)
Cash and cash equivalents at start of the period282,794413,970
Cash and cash equivalents at end of the period398,229246,808
Increase/ (decrease) in cash and cash equivalents115,435(167,162)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.